Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries United Therapeutic (NQ: UTHR ) 410.00 +7.43 (+1.85%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about United Therapeutic < Previous 1 2 3 Next > United Therapeutics Corporation to Present at the UBS Global Healthcare Conference November 05, 2024 From United Therapeutics Corporation Via Business Wire United Therapeutics Corporation Reports Third Quarter 2024 Financial Results October 30, 2024 From United Therapeutics Corporation Via Business Wire United Therapeutics Corporation Announces the 500th Lung Transplant Utilizing its Centralized Ex Vivo Lung Perfusion Service October 23, 2024 From United Therapeutics Corporation Via Business Wire United Therapeutics Corporation to Report Third Quarter 2024 Financial Results Before the Market Opens on Wednesday, October 30, 2024 October 23, 2024 From United Therapeutics Corporation Via Business Wire United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2024 Annual Meeting September 24, 2024 From United Therapeutics Corporation Via Business Wire United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind—Ever September 10, 2024 From United Therapeutics Corporation Via Business Wire United Therapeutics Corporation to Present at Upcoming Investor Conferences August 28, 2024 From United Therapeutics Corporation Via Business Wire United Therapeutics Corporation Reports Second Quarter 2024 Financial Results July 31, 2024 From United Therapeutics Corporation Via Business Wire United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024 July 24, 2024 From United Therapeutics Corporation Via Business Wire United Therapeutics Corporation Announces Full Enrollment of the TETON 2 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis July 10, 2024 From United Therapeutics Corporation Via Business Wire United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors June 27, 2024 From United Therapeutics Corporation Via Business Wire United Therapeutics Corporation to Present at the Goldman Sachs 45th Annual Global Healthcare Conference June 05, 2024 From United Therapeutics Corporation Via Business Wire United Therapeutics Corporation Reports First Quarter 2024 Financial Results May 01, 2024 From United Therapeutics Corporation Via Business Wire CORRECTING and REPLACING PHOTO United Therapeutics Announces World’s First Successful Xenothymokidney Transplant April 26, 2024 From United Therapeutics Corporation Via Business Wire United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024 April 24, 2024 From United Therapeutics Corporation Via Business Wire United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference April 16, 2024 From United Therapeutics Corporation Via Business Wire United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation March 26, 2024 From United Therapeutics Corporation Via Business Wire United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program March 25, 2024 From United Therapeutics Corporation Via Business Wire United Therapeutics Corporation to Present at the Leerink Partners Global Biopharma Conference 2024 March 05, 2024 From United Therapeutics Corporation Via Business Wire United Therapeutics Corporation to Present at the TD Cowen 44th Annual Health Care Conference February 27, 2024 From United Therapeutics Corporation Via Business Wire United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results February 21, 2024 From United Therapeutics Corporation Via Business Wire United Therapeutics Commences Litigation to Ensure Fairness in the Drug Review Process February 21, 2024 From United Therapeutics Corporation Via Business Wire United Therapeutics Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference December 29, 2023 From United Therapeutics Corporation Via Business Wire Liquidia: Court victory the awakening of an industry giant? December 27, 2023 Liquidia's stock surged after an enormous court win against United Therapeutics, accompanied by analyst upgrades and insider buying. Via MarketBeat Topics Intellectual Property Exposures Intellectual Property United Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and Merger December 13, 2023 From United Therapeutics Corporation Via Business Wire United Therapeutics and Miromatrix Medical Announce Successful Tender Offer December 12, 2023 From United Therapeutics Corporation Via Business Wire United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2024 December 07, 2023 From United Therapeutics Corporation Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Eargo, Inc. (Nasdaq – EAR), Miromatrix Medical, Inc. (Nasdaq – MIRO), Physicians Realty Trust (NYSE – DOC), Spirit Realty Capital (NYSE – SRC) November 13, 2023 From Brodsky & Smith LLC Via GlobeNewswire United Therapeutics Corporation Reports Third Quarter 2023 Financial Results November 01, 2023 From United Therapeutics Corporation Via Business Wire United Therapeutics Announces First Patient Enrolled in Phase 3 TETON PPF Study of Nebulized Tyvaso in Patients with Progressive Pulmonary Fibrosis October 31, 2023 From United Therapeutics Corporation Via Business Wire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
